Press release
Advanced Therapy Medicinal Products CDMO Market Deep Research Report with Forecast to 2034
The global Advanced Therapy Medicinal Products CDMO Market Size is valued at 6.7 Billion in 2024 and is predicted to reach 26.6 Billion by the year 2034 at a 15.0% CAGR during the forecast period for 2025-2034.
Request for Sample Pages:
https://www.insightaceanalytic.com/request-sample/1369
Advanced Therapeutic Medicinal Products (ATMPs) encompass a specialized category of biopharmaceuticals that includes tissue-engineered products, cell therapies, and gene therapies. The ATMP market is experiencing significant growth, driven by increasing awareness and confidence among researchers regarding the therapeutic potential of these innovations. Additionally, the rising number of clinical trials focused on advanced therapies is further accelerating market expansion.
The demand for ATMPs is surging due to the prevalence of rare and life-threatening diseases, including metabolic disorders and ophthalmic conditions. Increased funding for research and development (R&D) of next-generation therapies is further supporting market growth. Additionally, mesenchymal stem cells (MSCs), a key component of ATMPs, have emerged as a promising treatment option for addressing COVID-19-related complications.
List of Prominent Players in the Advanced Therapy Medicinal Products CDMO Market:
• Celonic
• Bio Elpida
• CGT Catapult
• Rentschler Biopharma SE
• AGC Biologics
• Catalent
• Lonza
• WuXi Advanced Therapies
• BlueReg
• Minaris Regenerative Medicine
• Patheon
Market Dynamics:
Drivers-
The Advanced Therapy Medicinal Products (ATMP) Contract Development and Manufacturing Organization (CDMO) market is experiencing significant growth, primarily driven by the continuous development of innovative therapeutic products. This surge is attributed to the increasing global demand for advanced therapies, particularly in the realms of gene and cell therapy. Biopharmaceutical companies are increasingly outsourcing manufacturing services to CDMOs, aiming to concentrate on their core competencies. CDMOs offer comprehensive services, encompassing clinical trial preparation and drug manufacturing, thereby streamlining the development process for their clients.
Curious about this newest model of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1369
Challenges:
Despite the promising growth, the ATMP CDMO market faces notable challenges. The high costs associated with advanced therapy medicinal products pose affordability issues, particularly for uninsured patients. While reimbursement programs in regions like the United States and the European Union cover many products, the financial burden remains substantial for those without insurance coverage.
Regional Trends:
In 2023, North America dominated the ATMP CDMO market, accounting for 49.0% of the global share. This leadership is attributed to increased outsourcing activities and heightened awareness of advanced therapies. The region's robust research and development initiatives have further solidified its market position. Notably, recent approvals of products such as Kymriah and Yescarta have propelled investments in the regional market. Additionally, in March 2021, the U.S. FDA approved Abecma, marking a significant milestone in CAR-T cell therapies for cancer treatment.
The Asia-Pacific region is projected to experience the fastest growth rate over the forecast period. This anticipated expansion is driven by the increasing demand for novel ATMPs and rising R&D activities aimed at developing innovative therapies. Countries within this region are enhancing their treatment technologies and expanding outsourcing activities, positioning themselves as significant players in the global ATMP CDMO market.
Recent Developments:
• In November 2020, Catalent will acquire Bone Therapeutics' cell therapy manufacturing unit. This acquisition has enabled the corporation to broaden its capabilities for pursuing new goods in its industry.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1369
Segmentation of Advanced Therapy Medicinal Products CDMO Market-
By Product-
• Gene Therapy
• Cell Therapy
• Tissue Engineered
• Others (Combined ATMPs, for example, biodegradable matric or scaffold)
By Phase-
• Phase I
• Phase II
• Phase III
• Phase IV
By Indication
• Oncology
• Cardiology
• Central Nervous System
• Musculoskeletal
• Infectious Disease
• Dermatology
• Endocrine, Metabolic, Genetic
• Immunology & Inflammation
• Ophthalmology
• Hematology
• Gastroenterology
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Get more information: @
https://www.insightaceanalytic.com/report/global-advanced-therapy-medicinal-products-cdmo-market/1369
Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Advanced Therapy Medicinal Products CDMO Market Deep Research Report with Forecast to 2034 here
News-ID: 3945146 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
4PL Logistics Market Revenue Report with Forecast to 2034
"4PL Logistics Market" in terms of revenue was estimated to be worth $59.6 Billion in 2024 and is poised to reach $133.3 Billion by 2034, growing at a CAGR of 8.5% from 2025 to 2034 according to a new report by InsightAce Analytic.
Get Free Sample Report @
https://www.insightaceanalytic.com/request-sample/1609
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global 4PL Logistics Market are:
• Rapid growth of automotive the…
Heavy-Duty Autonomous Vehicle Market Exclusive Trends Analysis with Forecast to …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Heavy-Duty Autonomous Vehicle Market- (By Application (Logistics, Public Transportation, Construction and Mining, Others), By Propulsion Type (Internal Combustion Engine Vehicles, Electric Vehicles), By Vehicle Type (Heavy Trucks, Heavy Buses, Roboshuttles), By Level of Autonomy (Fully Autonomous Vehicles, Semi-Autonomous Vehicles), By Sensor Type (LiDAR, RADAR, Camera, Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According…
E-Commerce Logistics Market Exclusive Report with Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-Commerce Logistics Market Size, Share & Trends Analysis Report By Service Type (Transportation And Warehousing) And Operational Area (International And Domestic)- Market Outlook And Industry Analysis 2034"
The global e-commerce logistics market is estimated to reach over USD 5340.2 billion by 2034, exhibiting a CAGR of 26.4% during the forecast period.
Request For Free Sample Pages:…
E-bikes Market Exclusive Report on the Latest Revenue and Future Scope
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-bikes Market Size, Share & Trends Analysis Report By Class (Class-I, Class-II, Class-III), Speed (Up to 25km/h, 25-45 km/h), Battery Type (Lithium-ion, Lithium-ion Polymer, Lead Acid), Mode (Pedal Assist, Throttle), Component (batteries, electric motors, frames with forks, wheels, crank gears, brake systems and motor controllers) , Motor Type (hub and mid), Usage (mountain, trekking, city/urban,…
More Releases for CDMO
Global Cmo And Cdmo Biotechnology Market Size by Application, Type, and Geograph …
According to Market Research Intellect, the global Cmo And Cdmo Biotechnology market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
Biologics and sophisticated medicines are driving the biotechnology industry for Contract Manufacturing Organizations (CMO) and Contract…
Evolving Market Trends In The Inhalation CDMO Industry: Strategic Collaborations …
The Inhalation CDMO Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Inhalation CDMO Market Size During the Forecast Period?
In recent times, the inhalation CDMO market has experienced significant growth. The market value is expected to increase from $2.08 billion in 2024…
What's Driving the Inhalation CDMO Market 2025-2034: Rising Respiratory Disorder …
How Is the Chondroplasty Market Projected to Grow, and What Is Its Market Size?
The chondroplasty market has seen strong growth in recent years. It will increase from $13.77 billion in 2024 to $14.68 billion in 2025 at a CAGR of 6.5%. This growth is attributed to the rise in sports-related injuries, patient preference for non-total joint replacement procedures, advances in postoperative care, healthcare provider training, and an increasing incidence of…
Lentiviral Vector (LVV) CDMO Services Market Delivering Cures: The Role of LVV C …
Lentiviral Vector (LVV) CDMO Services Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Lentiviral Vector (LVV) CDMO Services Market - (By Type (IIT Grade, IND Grade, Clinical Trial Grade, Commercial Production Grade), By Application (Biopharmaceutical Company, Academic Scientific Research Institution)), Trends, Industry Competition Analysis, Revenue and Forecast To…
Electronic Chemicals CDMO Market Fueling the Electronics Boom: The Rise of the E …
Electronic Chemicals CDMO Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Electronic Chemicals CDMO Market - (By Type (Metals and Pastes, Electronic Specialty Gases, Polymer Compounds, Others), By Application (Battery, Semiconductor, Integrated Circuit, Consumer Electronics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest…
Peptide CDMO Market Size 2024 to 2031.
Market Overview and Report Coverage
A Peptide CDMO (Contract Development and Manufacturing Organization) is a company that provides services for the development and manufacturing of peptides, which are short chains of amino acids used in various pharmaceutical and biotechnological applications.
The future outlook of the Peptide CDMO Market looks promising, with a projected growth rate of 15.10% during the forecasted period. This growth is fueled by the increasing demand for…
